Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial carnitine O-palmitoyltransferase 1A (CPT1A) is a key enzyme located on the outer mitochondrial membrane. It catalyzes the transfer of long-chain fatty acyl groups from coenzyme A to L-carnitine, forming acylcarnitines. This reaction is essential for transporting long-chain fatty acids into mitochondria for β-oxidation, making CPT1A a rate-limiting step in mitochondrial fatty acid oxidation. CPT1A is predominantly expressed in liver, kidney, pancreas, adipose tissue, lymphocytes, and fibroblasts. It is inhibited by malonyl-CoA, providing tight regulation between lipid synthesis and degradation pathways. Deficiency or dysfunction of CPT1A impairs hepatic ketogenesis and energy production from fats, especially during fasting, and can result in hypoketotic hypoglycemia. Altered expression or localization has been observed in various cancers.
Catalyzes transfer of long-chain acyl groups from Coenzyme A to carnitine, enabling transport of activated fatty acids into mitochondria for β-oxidation. Inhibition by malonyl-CoA regulates lipid synthesis and degradation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Carnitine O-palmitoyltransferase 1A (None).